170 related articles for article (PubMed ID: 23093023)
1. Phosphoinositide-dependent kinase-1 and protein kinase Cδ contribute to endothelin-1 constriction and elevated blood pressure in intermittent hypoxia.
Webster BR; Osmond JM; Paredes DA; DeLeon XA; Jackson-Weaver O; Walker BR; Kanagy NL
J Pharmacol Exp Ther; 2013 Jan; 344(1):68-76. PubMed ID: 23093023
[TBL] [Abstract][Full Text] [Related]
2. Eucapnic intermittent hypoxia augments endothelin-1 vasoconstriction in rats: role of PKCdelta.
Allahdadi KJ; Duling LC; Walker BR; Kanagy NL
Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H920-7. PubMed ID: 18083893
[TBL] [Abstract][Full Text] [Related]
3. ROK contribution to endothelin-mediated contraction in aorta and mesenteric arteries following intermittent hypoxia/hypercapnia in rats.
Allahdadi KJ; Walker BR; Kanagy NL
Am J Physiol Heart Circ Physiol; 2007 Nov; 293(5):H2911-8. PubMed ID: 17720771
[TBL] [Abstract][Full Text] [Related]
4. Endothelin-1-induced vasoconstriction does not require intracellular Ca²⁺ waves in arteries from rats exposed to intermittent hypoxia.
Osmond JM; Gonzalez Bosc LV; Walker BR; Kanagy NL
Am J Physiol Heart Circ Physiol; 2014 Mar; 306(5):H667-73. PubMed ID: 24414066
[TBL] [Abstract][Full Text] [Related]
5. Augmented endothelin vasoconstriction in intermittent hypoxia-induced hypertension.
Allahdadi KJ; Walker BR; Kanagy NL
Hypertension; 2005 Apr; 45(4):705-9. PubMed ID: 15738350
[TBL] [Abstract][Full Text] [Related]
6. Endothelin type A receptor antagonist normalizes blood pressure in rats exposed to eucapnic intermittent hypoxia.
Allahdadi KJ; Cherng TW; Pai H; Silva AQ; Walker BR; Nelin LD; Kanagy NL
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H434-40. PubMed ID: 18515645
[TBL] [Abstract][Full Text] [Related]
7. Simulated sleep apnea alters hydrogen sulfide regulation of blood flow and pressure.
Barrera A; Morales-Loredo H; Garcia JM; Fregoso G; Pace CE; Mendiola PJ; Naik JS; Gonzalez Bosc LV; Kanagy NL
Am J Physiol Heart Circ Physiol; 2021 Feb; 320(2):H511-H519. PubMed ID: 33275519
[TBL] [Abstract][Full Text] [Related]
8. Role for PKCβ in enhanced endothelin-1-induced pulmonary vasoconstrictor reactivity following intermittent hypoxia.
Snow JB; Gonzalez Bosc LV; Kanagy NL; Walker BR; Resta TC
Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L745-54. PubMed ID: 21803871
[TBL] [Abstract][Full Text] [Related]
9. Intermittent hypoxia-induced increases in reactive oxygen species activate NFATc3 increasing endothelin-1 vasoconstrictor reactivity.
Friedman JK; Nitta CH; Henderson KM; Codianni SJ; Sanchez L; Ramiro-Diaz JM; Howard TA; Giermakowska W; Kanagy NL; Gonzalez Bosc LV
Vascul Pharmacol; 2014 Jan; 60(1):17-24. PubMed ID: 24239798
[TBL] [Abstract][Full Text] [Related]
10. NFAT regulation of cystathionine γ-lyase expression in endothelial cells is impaired in rats exposed to intermittent hypoxia.
Gonzalez Bosc LV; Osmond JM; Giermakowska WK; Pace CE; Riggs JL; Jackson-Weaver O; Kanagy NL
Am J Physiol Heart Circ Physiol; 2017 Apr; 312(4):H791-H799. PubMed ID: 28130342
[TBL] [Abstract][Full Text] [Related]
11. Reactive oxygen species contribute to sleep apnea-induced hypertension in rats.
Troncoso Brindeiro CM; da Silva AQ; Allahdadi KJ; Youngblood V; Kanagy NL
Am J Physiol Heart Circ Physiol; 2007 Nov; 293(5):H2971-6. PubMed ID: 17766485
[TBL] [Abstract][Full Text] [Related]
12. Intermittent Hypoxia Augments Pulmonary Vasoconstrictor Reactivity through PKCβ/Mitochondrial Oxidant Signaling.
Snow JB; Norton CE; Sands MA; Weise-Cross L; Yan S; Herbert LM; Sheak JR; Gonzalez Bosc LV; Walker BR; Kanagy NL; Jernigan NL; Resta TC
Am J Respir Cell Mol Biol; 2020 Jun; 62(6):732-746. PubMed ID: 32048876
[TBL] [Abstract][Full Text] [Related]
13. A dual blocker of endothelin A/B receptors mitigates hypertension but not renal dysfunction in a rat model of chronic kidney disease and sleep apnea.
Morales-Loredo H; Jones D; Barrera A; Mendiola PJ; Garcia J; Pace C; Murphy M; Kanagy NL; Gonzalez Bosc LV
Am J Physiol Renal Physiol; 2019 May; 316(5):F1041-F1052. PubMed ID: 30810064
[TBL] [Abstract][Full Text] [Related]
14. NFATc3 is required for intermittent hypoxia-induced hypertension.
de Frutos S; Duling L; Alò D; Berry T; Jackson-Weaver O; Walker M; Kanagy N; González Bosc L
Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2382-90. PubMed ID: 18359899
[TBL] [Abstract][Full Text] [Related]
15. The phosphoinositide-dependent kinase-1 inhibitor 2-amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-acetamide (OSU-03012) prevents Y-box binding protein-1 from inducing epidermal growth factor receptor.
To K; Zhao Y; Jiang H; Hu K; Wang M; Wu J; Lee C; Yokom DW; Stratford AL; Klinge U; Mertens PR; Chen CS; Bally M; Yapp D; Dunn SE
Mol Pharmacol; 2007 Sep; 72(3):641-52. PubMed ID: 17595327
[TBL] [Abstract][Full Text] [Related]
16. NFATc3 contributes to intermittent hypoxia-induced arterial remodeling in mice.
de Frutos S; Caldwell E; Nitta CH; Kanagy NL; Wang J; Wang W; Walker MK; Gonzalez Bosc LV
Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H356-63. PubMed ID: 20495147
[TBL] [Abstract][Full Text] [Related]
17. Major role for hypoxia inducible factor-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea.
Belaidi E; Joyeux-Faure M; Ribuot C; Launois SH; Levy P; Godin-Ribuot D
J Am Coll Cardiol; 2009 Apr; 53(15):1309-17. PubMed ID: 19358946
[TBL] [Abstract][Full Text] [Related]
18. Prenatal testosterone exposure induces hypertension in adult females via androgen receptor-dependent protein kinase Cδ-mediated mechanism.
Blesson CS; Chinnathambi V; Hankins GD; Yallampalli C; Sathishkumar K
Hypertension; 2015 Mar; 65(3):683-690. PubMed ID: 25489059
[TBL] [Abstract][Full Text] [Related]
19. Role of endothelin in intermittent hypoxia-induced hypertension.
Kanagy NL; Walker BR; Nelin LD
Hypertension; 2001 Feb; 37(2 Pt 2):511-5. PubMed ID: 11230327
[TBL] [Abstract][Full Text] [Related]
20. OSU-03012 promotes caspase-independent but PERK-, cathepsin B-, BID-, and AIF-dependent killing of transformed cells.
Yacoub A; Park MA; Hanna D; Hong Y; Mitchell C; Pandya AP; Harada H; Powis G; Chen CS; Koumenis C; Grant S; Dent P
Mol Pharmacol; 2006 Aug; 70(2):589-603. PubMed ID: 16622074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
